 The companies take issue with the provision of the expansive law that requires them to restrict, prohibit, or interfere with the delivery of a drug available through a federal program that helps send discounted medicines to hospitals that treat low-income and uninsured patients. The company said Minnesota doesn't have the authority to enforce the program or to require drug makers to turn over their property without due process.